USC Price School of Public Policy

Lakdawalla on long-term financial benefits of treating hepatitis C

May 18, 2016

KPCC-FM featured research by Darius Lakdawalla of the USC Schaeffer Center on how treating hepatitis C in the long-term is more cost effective than continuing existing treatments. “Unfortunately, the conventional wisdom is, if there’s an expensive drug, the way to ration it is to treat people who are sickest, but it turns out that’s kind of backwards from where the value really lies,” Lakdawalla said.